Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. I. Absorption, distribution and excretion in rats.
D000284:Administration, Oral; D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism*; D001646:Bile / Q000032:analysis; D001921:Brain / Q000378:metabolism; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000378:metabolism; D002855:Chromatography, Thin Layer; D003510:Cyclohexanes / Q000008:administration & dosage / Q000378:metabolism; D005243:Feces / Q000032:analysis; D005260:Female; D005333:Fetus; D005753:Gastric Mucosa / Q000378:metabolism; D006207:Half-Life; D007192:Indenes / Q000008:administration & dosage / Q000378:metabolism*; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008431:Maternal-Fetal Exchange; D009928:Organ Specificity; D011247:Pregnancy; D051381:Rats; D014316:Tritium
D000893:Anti-Inflammatory Agents; D002264:Carboxylic Acids; D003510:Cyclohexanes; D007192:Indenes; D014316:Tritium